The FDA is adding a new “black box” warning to the psoriasis drug Raptiva. Side effects could include an increased risk of potentially life-threatening infections, including the brain disease progressive multifocal leukoencephalopathy (PML). Continued
All Posts Tagged With: "Progressive Multifocal Leukoencephalopathy (PML)"
Raptiva Lawsuits
The psoriasis drug Raptiva’s side effects could lead to serious and potentially life-threatening infections, including the rare brain disease progressive multifocal leukoencephalopathy (PML). Continued
Tysabri PML Cases Cause European Regulators to Recommend Stronger Warnings
The European Medicines Agency, an advisory body for drug regulators in Europe, recommended last week that the warning label for the multiple-sclerosis drug Tyasabri be updated following new reports of users developing a rare brain disease known as PML, or progressive multifocal leukoencephalopathy. Continued
Rituxan Side Effects Linked to Progressive Multifocal Leukoencephalopathy (PML)
On Thursday, the FDA notified oncologists, rheumatologists and other healthcare providers that the rheumatoid arthritis drug Rituxan has been linked to a fatal case of progressive multifocal leukoencephalopathy (PML). An update will be made to the prescription information about the risk of developing the rare brain disease. Continued
FDA Informs Doctors about Reports of Progressive Multifocal Leukoencephalopathy (PML)
The FDA has issued a notice to healthcare providers with information about two new reports of progressive multifocal leukoencephalopathy (PML), a rare brain disease, which have occurred among two patients in Europe who were receiving the multiple sclerosis drug Tysabri. Continued
Tysabri Linked to Two More Cases of Progressive Brain Disease
Two new cases of a rare brain disease, known as Progressive Multifocal Leukoencephalopathy, have been reported among users of the multiple sclerosis drug Tysabri. This has renewed concerns about the side effects of Tysabri, which was temporarily pulled from the market in 2005 as a result of a connection with the potentially fatal neurological disease. Continued
Tysabri Lawsuits
Side effects of Tysabri have been linked to an increased risk of liver damage, as well as a risk of a rare and potentially fatal brain disease known as Progressive Multifocal Leukoencephalopathy. Continued
Progressive Multifocal Leukoencephalopathy Lawsuits
The rare and potentially fatal brain disease, Progressive Multifocal Leukoencephalopathy (PML) has been linked to the use of several medications. Potential lawsuits are being investigated by PML lawyers for individuals who have been diagnosed with the neurological disease which may have been linked to a medication. Continued
Warning Added for Progressive Multifocal Leukoencephalopathy to CellCept and Myfortic
Roche and Novartis have added warnings to their organ transplant medications, CellCept and Myfortic, indicating an association with Progressive Multifocal Leukoencephalopathy, a rare and potentially fatal neurological condition. Continued
CellCept Lawsuits
In November 2007, a black boxed warning was added to the organ transplant medication about an increased risk of birth defects, such as cleft palate, cleft lip and ear deformities, when taken during pregnancy. In June 2008, information was added to the prescribing information about another possible side effect of CellCept, which could lead to a rare neurological disease that is often fatal. Continued
